<i>In Vitro</i> Antibacterial Activity of Imipenem/Relebactam against Clinical Isolates in Japan-Reference-Cited by-同舟云学术

In Vitro Antibacterial Activity of Imipenem/Relebactam against Clinical Isolates in Japan

Published:2022-04-27 Issue:2 Volume:10 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Kurihara Dai¹^ORCID,Matsumoto Satoru²,Kishi Naoko²,Ishii Yoshikazu³^ORCID,Mori Masahiko¹

Affiliation:

1. Japan Development, MSD K.K., Tokyo, Japan

2. Microbiological Testing Group, Infectious Diseases Testing Department, Clinical Laboratory Center, Medical Solution Segment, LSI Medience Corporation, Tokyo, Japan

3. Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan

Abstract

Carbapenem-resistant Enterobacterales and carbapenem-resistant Pseudomonas aeruginosa strains pose a global threat. Antibacterial activity of imipenem/relebactam (IMR) against clinical isolates of these bacteria from several global regions has been shown; however, as yet there are no reports on Japanese isolates.

Funder

Merck & Co. | MSD K.K.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.02235-21

Reference38 articles.

1. Two decades of imipenem therapy

2. Imipenem/Cilastatin

3. Clinical and Laboratory Standards Institute. 2021. Performance standards for antimicrobial susceptibility testing, 31st ed. CLSI supplement M100. CLSI, Wayne, PA, USA.

4. World Health Organization. 2017. Prioritization of pathogens to guide discovery research and development of new antibiotics for drug-resistant bacterial infections including tuberculosis. WHO Geneva Switzerland.

5. In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global Resistance of Imipenem/Relebactam against Gram-Negative Bacilli: Systematic Review and Meta-Analysis;Current Therapeutic Research;2024

2. Klebsiella pneumoniae Susceptibility to Carbapenem/Relebactam Combinations: Influence of Inoculum Density and Carbapenem-to-Inhibitor Concentration Ratio;Biomedicines;2022-06-20